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ABSTRACT
Background Traditional treatment of amblyopia
involves either wearing a patch or atropine penalisation
of the better eye. A new treatment is being developed
on the basis of virtual reality technology allowing either
DVD footage or computer games which present a
common background to both eyes and the foreground,
containing the imagery of interest, only to the amblyopic
eye.
Methods A randomised control trial was performed on
patients with amblyopia aged 4–8 years with three
arms. All three arms had dichoptic stimulation using
shutter glass technology. One arm had DVD footage
shown to the amblyopic eye and common background to
both, the second used a modiﬁed shooter game, Nux,
with sprite and targets presented to the amblyopic eye
(and background to both) while the third arm had both
background and foreground presented to both eyes
(non-interactive binocular treatment (non-I-BiT) games).
Results Seventy-ﬁve patients were randomised; 67
were residual amblyopes and 70 had an associated
strabismus. The visual acuity improved in all three arms
by approximately 0.07 logMAR in the amblyopic eye at
6 weeks. There was no difference between I-BiT DVD
and non-I-BiT games compared with I-BiT games (stated
primary outcome) in terms of gain in vision.
Conclusions There was a modest vision improvement
in all three arms. Treatment was well tolerated and safe.
There was no difference between the three treatments in
terms of primary stated outcomes but treatment duration
was short and the high proportion of previously treated
amblyopia and strabismic amblyopia disadvantaged
dichoptic stimulation treatment.
Trial registration number NCT01702727, results.
INTRODUCTION
The mainstay of treatment for amblyopia caused by
anisometropia or strabismus, after correction of
refractive error, is occlusion, by patching, of the
normal eye. This idea of ‘forcing’ the amblyopic
eye to see dates at least as far back as de Buffon.1
There is a sensitive period for the development of
the visual system during which patching is effective.
It is more effective for younger children but a ran-
domised control trial of patching has shown that
about half of children with amblyopia in the 7–
12 year age range will respond to optical treatment
and patching.2 Some children over the age of
12 years also improved but only if they had not
received previous treatment.2
The additive effect of patching after spectacle
adaptation is modest. A randomised control trial of
patching in children who had 16 weeks of full
refractive correction gained a further 1.3 lines in the
control group (spectacle correction alone can con-
tinue to improve vision for up to 30 weeks) and 2.2
lines in those who had 2 h of patching per day.3 The
effectiveness of patching depends upon the degree
of amblyopia with little beneﬁt for those with mild
levels of amblyopia (6 September–6 December).4 In
the 1850s, Javal introduced atropine penalisation
which is as effective as patching5–8 and the two
treatments are not additive—nothing is to be gained
by combining them.9
Current treatments are only moderately effective
with amblyopia persisting beyond the age of
16 years in 80% of patients.10 A further drawback
shared by both patching and penalisation is that
they are ‘dissociative’ and do nothing to encourage
the amblyopic and the normal eye to work in
harmony together. Furthermore, compliance with
patching is often poor with up to 50% of patients
not complying with the prescribed dosage,11 sug-
gesting that the treatment is not popular with chil-
dren. There is clearly a need for something better.
These considerations led us to develop a virtual
reality-based system12 to treat amblyopia using
dichoptic stimulation in the context of either
playing special video games or watching DVDs.
This interactive binocular treatment (I-BiT) system
uses specially conﬁgured software to preferentially
stimulate the amblyopic eye without compromising
the vision in the good eye.
Three pilot studies13–15 have shown the I-BiT
system can improve the visual acuity in patients
with amblyopia. The most recent of these pilot
studies using shutter glasses technology15 showed
that all patients who completed their planned treat-
ment (9 of the 10 patients) showed an improve-
ment in visual acuity from 0.025 to 0.45 logMAR
units with a mean of 0.18 (SD 0.14).
On the basis of these results, we decided to
proceed to a small two centre randomised control
trial with the intention of ensuring that the treat-
ment was safe, acceptable and to get an improved
indication of its efﬁcacy.
MATERIALS AND METHODS
Trial design
The full trial design and protocol is available from
a previous publication.16
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The study was a randomised parallel group design with the
intention to recruit 75 patients. The eligible patients were ran-
domised to one of three treatments.
▸ I-BiT game
▸ Non-I-BiT game
▸ I-BiT DVD.
Each received their randomised treatment weekly for 6 weeks,
for a 30 min period.
At baseline their logMAR visual acuity, with glasses if
required, was recorded along with the results of their cover test,
oculomotility assessment, binocular vision assessment, visuo-
scope and Sbisa bar results.
Visual acuity was assessed pretreatment (week 1), after three
treatments (week 3), after six treatments (week 6) and 4 weeks
after their ﬁnal treatment (week 10). Visual acuity was assessed
with either the logMAR crowded test (formally Glasgow acuity
cards, manufactured by Keeler) or the crowded Kay’s picture
test. Choice of visual acuity (VA) test was dependent on the par-
ticipant’s ability and remained consistent throughout the trial.
Participants and recruitment
Children aged 4–8 years with strabismic, anisometropic or
mixed amblyopia were recruited from two test sites (Queen’s
Medical Centre, Nottingham and Addenbrooke’s Hospital,
Cambridge), from January 2012 to November 2013. Stimulus
deprivation amblyopia was excluded.
Children who had prior treatment with either patching or
atropine penalisation were eligible for recruitment providing
they had a 0.20 logMAR intraocular acuity difference and no
current improvement with patching. Those whose suppression
measured four or less on the Sbisa bar were deemed at risk of
double vision and were excluded. For full list of inclusion and
exclusion criteria, see the protocol paper.16
Interventions
I-BiT shutter glasses system
The I-BiT system hardware is designed for use under supervision
and consists of a desktop PC with two monitors, one for the
clinician and one for the patient. The clinician monitor is used
to control the treatment the patient receives and the patient
monitor displays the visual stimuli. The patient monitor is a
ﬂat-screen 22-inch 3D monitor with a refresh rate of 120 Hz
and this allows separate images to be presented to each eye with
the use of shutter glasses. The shutter glass lenses lighten and
darken in synchrony with the monitor but faster than the user
can perceive and this allows a common background to be pre-
sented to both eyes and an ‘enriched’ image to be presented
only to the amblyopic eye (dichoptic stimulation). The I-BiT
Figure 1 The Consolidated Standards
of Reporting Trials (CONSORT) ﬂow
diagram for the trial.
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system can display video footage and interactive games.
A gaming control pad is used for the games.
DVD stimulus
The I-BiT DVD stimulus is divided into two zones. There is an
outer ‘border’ termed a locking stimulus which is presented to
both eyes while the inner part of the screen presents the video
footage predominately to the amblyopic eye.
Game stimulus
An interactive game called ‘Nux’ was used to provide the game
play. Through the I-BiT system, the player and the background
are shown to both eyes but the obstacles, enemies and coins are
shown only to the amblyopic eye. Therefore, in order for the
child to play the game successfully, they must use their ambly-
opic eye.
Control stimulus
In the non-I-BiT game version (control arm) both eyes receive
identical stimulation.
Outcomes
The primary objectives of the study were:
1. To determine the difference in visual acuity improvement in
patients treated with I-BiT compared with non-I-BiT
treatment.
2. To determine the difference in effectivity between the inter-
active games and DVDs.
The primary outcome measure was the change in logMAR
visual acuity from week 1 (pretreatment) to week 6
(post-treatment).
The secondary outcome measures included changes in
stereoacuity (Frisby test), and the safety, acceptability and com-
pliance of treatment.
Loss of visual acuity of 0.1 logMAR units at week 3 or
double vision induced withdrawal from the trial.
Sample size
The sample size of 75 patients (25 in each arm) was calculated
assuming an SD of 0.25 with the aim to detect a minimum dif-
ference of 0.2 logMAR units at the 5% signiﬁcance level (two-
sided) with 80% power.
Randomisation
The randomisation sequence was generated using the RALLOC
function in Stata V.10 and used random permuted blocks of
sizes 2, 4 and 6. It was stratiﬁed by centre and whether or not
the patient had previous treatment for amblyopia.
Masking
The research orthoptist who delivered the treatment was aware
of the patient allocation but not of visual acuity measurements
which were performed by an independent orthoptist who was
masked to the treatment allocation.
Statistical methods
Data analysis was performed using Stata V.11.2. Intention to
treat analysis was performed for the primary outcome. All
missing data were assumed to be missing completely at random
and imputation methods were not used to compensate for
missing data.
The primary endpoint of change in visual acuity from week 1
to end of treatment (week 6) was compared between the treat-
ment groups using Analysis of Covariance (ANCOVA) with
baseline visual acuity as covariate. The change in visual acuity
from week 1 to week 3 and 10 was compared between the treat-
ment groups using ANCOVA with baseline visual acuity as cov-
ariate. Difference within groups from baseline to 3, 6 and
10 weeks post-treatment was tested for using a two-tailed paired
t test. The proportion of patients showing a clinically important
change in VA (≥0.125 logMAR) from baseline at 3, 6 and
10 weeks was compared between the three groups using Fisher’s
exact test. The frequency (%) of patients’ satisfaction, compli-
ance with treatment and adverse events were also analysed.
Unplanned secondary analyses of the change in VA for all par-
ticipants from baseline to weeks 3, 6 and 10 were performed
using a paired t test.
Ethical review
This study was approved by Nottingham Research Ethics
Committee 2.
RESULTS
Participant ﬂow and baseline data
The patient ﬂow is summarised in the Consolidated Standards
of Reporting Trials (CONSORT) diagram (ﬁgure 1) and the
baseline data in table 1 and further baseline data can be found
in the online supplementary ﬁle.
The visual acuity improved in all three groups at weeks 3, 6
and 10 with the average improvement of vision at week 6 of
Table 1 Summary of baseline characteristics of the study
population
I-BiT DVD I-BiT games Non-I-BiT games
Number randomised 24 26 25
Mean (SD) age (years) 5.9 (1.2) 6.0 (1.3) 5.6 (1.1)
Gender
Male (%) 13 (54%) 17 (65%) 13 (52%)
Female (%) 11 (46%) 9 (35%) 12 (48%)
Experience with computer games
Does not play 3 5 4
<30 min/day 12 7 12
30–60 min/day 6 10 4
1–2 h/day 2 4 3
>2 h/day 1 0 2
Type of amblyopia
Strabismic 13 6 5
Mixed 11 17 18
Anisometropic 0 3 2
Previous amblyopia treatment
Yes 19 20 18
Occlusion 19 20 17
Penalisation 4 3 7
None 5 6 7
Acuity in amblyopic eye at baseline (logMAR)
Mean 0.53 0.49 0.50
Range 0.36–0.65 0.38–0.55 0.35–0.65
SD 0.21 0.17 0.20
Fixation with amblyopic eye
Foveolar 3 1 2
Parafoveolar 5 11 4
Parafoveal 8 5 2
Eccentric 4 1 2
No view with amblyoscope 4 8 15
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0.07 logMAR which was sustained at week 10. This improve-
ment was signiﬁcant at all three time points (using paired t tests,
p<0.001 at all three time points) (table 2).
The primary outcome
The primary outcome measure was the difference in visual acuity
improvement between the three arms at week 6 with I-BiT games
as the comparison arm. The change in visual acuity from baseline
to the end of treatment (week 6) is shown in table 3.
There was no difference in the change from baseline between
those having I-BiT games and those having non-I-BiT games
(mean 0.02 logMAR units 95% CI (−0.07 to 0.03)). The improve-
ment in vision from baseline at 6 weeks differed between the two
games treatment groups and the DVD group, with a mean of
change in the I-BiT DVD group of −0.1 compared with −0.06 in
the I-BiT games group and −0.03 in the non-I-BiT games group.
Secondary outcomes
The change in vision at weeks 3 and 10, and the proportion of
patients with a clinically signiﬁcant improvement (deﬁned as
≥1.25 logMAR units) are summarised in table 3.
There were no signiﬁcant improvements in stereoacuity
(Frisby) in the three arms (see online supplementary material).
The I-BiT DVD and non-I-BiT game improved vision to week
6 then declined slightly after treatment ﬁnished (week 10). The
I-BiT games group increased from weeks 3–6 and then a
decrease to week 10. The mean VA at week 10 was less than
baseline for all three groups.
The patient satisfaction questionnaire showed that >90% of
participants felt that they enjoyed their treatment, >80% felt
that the time allowed was just right, and that 67% or more felt
that it was easy to concentrate.
Compliance with each of the treatments was excellent with
the majority of participants playing the game/watching the DVD
for 30 min at each session.
Adverse events
These are summarised in table 4. There were two cases of
double vision which were assumed to be adverse device effects
Table 3 Summary of outcomes
I-BiT DVD I-BiT games Non-I-BiT games
Number randomised 24 26 25
Primary outcome
Change from baseline to week 6 in visual acuity (logMAR)
N 21 25 22
Mean (SD) −0.1 (0.02) −0.06 (0.02) −0.03 (0.02)
Median (range) −0.1 (−0.15, 0.05) −0.05 (−0.13, 0) −0.04 (−0.1, 0.04)
Difference from I-BiT games
Mean (SE) 0.05 (0.03) 0.02 (0.03)
95% CI −0.004 to 0.10 −0.07 to 0.03
p Value (from ANCOVA with baseline VA as covariate) 0.067 0.429
Secondary outcomes
Change in VA from baseline to week 10
Change from baseline to week 10 in visual acuity (logMAR)
N 23 26 24
Mean (SE) −0.07 (0.03) −0.07 (0.03) −0.06 (0.02)
Median (IQR) −0.08 (−0.18, −0.02) −0.09 (−0.16, −0.07) −0.05 (−0.15, 0)
Difference from I-BiT games
Mean (SE) 0.003 (0.04) −0.01 (0.04)
95% CI −0.07 to 0.07 −0.08 to 0.06
Change in VA from baseline to week 3
Change from baseline to week 3 in visual acuity (logMAR)
N 24 26 24
Mean (SD) −0.05 (0.02) −0.05 (0.02) −0.02 (0.02)
Median (IQR) 0.07 (−0.12, −0.005) −0.04 (−0.1, 0.008) −0.03 (−0.08, 0.02)
Difference from I-BiT games
Mean (SE) 0.002 (0.03) −0.03 (0.02)
95% CI −0.06 to 0.06 −0.08 to 0.01
Proportion (%) of patients showing a clinically important change in VA (≥1.25 logMAR)
Week 3 6 (25%) 4 (15%) 1 (4%)
Week 6 6 (25%) 6 (23%) 4 (16%)
Week 10 10 (42%) 11 (42%) 8 (32%)
Table 2 Improvement in vision for all the patients in the trial
Improvement in
logMAR vision CIs p Value
Baseline and week 3 −0.04 −0.63 to −0.20 <0.001
Baseline and week 6 −0.07 −0.11 to −0.047 <0.0001
Baseline and week 10 −0.067 −0.097 to 0.038 <0.0001
Significance testing was performed using a paired t test and probability values
calculated on the basis of two-tailed.
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and they both resolved spontaneously following cessation of
treatment. All other adverse events are assumed to be not device
related.
DISCUSSION
There was a modest visual acuity improvement in all groups
including group 3 who received the non-I-BiT game. The
visual acuity improvement of 0.07 logMAR is less than the
0.18 which we had observed previously but is similar to the
0.1 improvement reported by Li et al.17 It was an unexpected
ﬁnding that the non-I-BiT game showed some improvement
in visual acuity and the reason is not clear. It is possible that
use of the shutter glasses alone may have improved amblyopic
vision. The control group had all of the game content shown
to both eyes but because of the shutter glasses it is, in reality,
only shown to one eye at a time. The shutter glasses operate
fast enough that the game content is perceived by both eyes
simultaneously. Dichoptic stimulation may itself improve
vision without the use of ‘preferential stimulation’ of the
amblyopic eye which occurred in the I-BiT game and I-BiT
DVD groups.
The study was disadvantaged by the fact that the majority of
participants in this trial (67/75) were residual amblyopes (con-
ventional patching failures) and there was a high proportion of
strabismic amblyopia (70/75). This represents a poor prognostic
group but the decision to allow previous amblyopia treatment
failures into the trial was based on the fact that they were far
easier and quicker to recruit. Another limiting factor was that
the treatment in this trial was hospital based during working
and school hours which limited the duration and frequency of
treatment sessions to only half an hour a week. The total treat-
ment time of only 3 h is very short when compared with patch-
ing where the Monitored Occlusion Treatment of Amblyopia
(MOTAS) group recommended at least 150 h and showed a
linear response for up to 400 h.18 The study by Li et al used an
I-Pad delivery system with 16 h of game play >4 weeks and
with no extra beneﬁt from a further 16 h over a further 4 week
period.17 Hess’s group, using an I-Pad at home19 showed that
1–2 h per day for 1–3 weeks can improve acuity, restore binocu-
larity and restore stereopsis in adults.20 Vedamurthy et al also
developed a dichoptic action videogame and with 40 h of treat-
ment in adults showed improvements in both anisometropic and
strabismic amblyopes of logMAR 0.14.21
There were two classes of adverse events that lead to patient
withdrawal diplopia and reduction visual acuity Double vision is
presumed to be due to the treatment reversing suppression and
was considered a device-related adverse event and the two cases
resolved fully on cessation of treatment. No adverse events have
been reported by other groups.
Patching and penalisation are not popular treatments and sys-
tematic reviews have suggested that the impact on health-related
quality of life for patients with amblyopia comes from the treat-
ment rather than the disease.22 23 This dichoptic stimulation
treatment was very acceptable and with a compliance rate of
>90%, much better than the 48% reported for patching.24
Others have also noted the high acceptability of computer
games as a vehicle for treatment.25 Amblyopia often coexists
with strabismus and 70 of the 75 patients in this trial had mani-
fest strabismus. Failure of the amblyopic eye to become the ﬁx-
ating eye may prevent dichoptic stimulation being an effective
treatment in patients with strabismus unless the stimulus can be
delivered to the fovea.
There was some improvement in vision in all three groups
after a total of 3 h of treatment which was well tolerated and
safe. There was no apparent advantage to differential target-
ing of the amblyopic eye with dichoptic stimulation.
However, the short total treatment time, high proportion of
previous amblyopia treatment failures and high proportion of
patients with strabismus disadvantage dichoptic stimulation
and this study does not suggest that a treatment beneﬁt is not
achievable. Further studies are being targeted at longer treat-
ment duration (requiring a home-based treatment), naïve
amblyopes and a greater proportions of anisometropic
amblyopes to determine whether the I-BiT system has the
potential to deliver a treatment for amblyopia which is more
acceptable and equally or more effective than conventional
treatment.
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